Updated cholesterol guidelines criticized for coronary artery CT scan recommendation

Updated cholesterol guidelines from the American Heart Association (AHA) and the American College of Cardiology suggest a more personalized approach to stroke risk assessment and for determining coronary artery calcium scores with CT scans, among other recommendations, according to an article published Nov. 11 by CNN. 

The new recommendations were announced Saturday, Nov. 10 during the AHA's annual scientific conference in Chicago. They also recommended a returned focus to low-density lipoprotein (LDL) target levels and new drug options for those at highest risk for cardiovascular disease, according to the article.  

Most notably, the new recommendations address criticism of previous guidelines last updated in 2013, Steven Nissen, MD, chairman of cardiovascular medicine at the Cleveland Clinic in Ohio, told CNN.  

While in support of the new guidelines overall, Nissen criticized the recommendation which suggested coronary artery calcium scores be measured with CT to determine the need for cholesterol-lowering treatments in uncertain patients. At the Cleveland Clinic, where he works, a scan for a coronary artery. calcium score costs less than $500, but a more thorough scan that includes angiography can exceed $1000, according to the study.

"You're radiating somebody in order to decide whether to use a drug that costs as little as $3 a month, and you're spending a lot of money to do it," Nissen said. "I just don't think it's prudent." 

Read CNN’s entire article below.

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.